BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study

Autor: R. Kaas, Caroline Seynaeve, Nicoline Hoogerbrugge, Sybren L. Meijer, Mieke Kriege, Rob A. E. M. Tollenaar, Emiel J. T. Rutgers, Jan G. M. Klijn, Martin N. J. M. Wasser, Claudette E. Loo, Harry J. de Koning, Carla Boetes, Inge-Marie Obdeijn, Madeleine M. A. Tilanus-Linthorst, C.C.M. Bartels, Jan C. Oosterwijk, Sara H. Muller, Adriana J. Rijnsburger, E. Bergers, Maartje J. Hooning, Paul I.M. Schmitz, Hans Peterse, Theo Kok

Publikováno v: Journal of Clinical Oncology, 28(36), 5265-5273
Rijnsburger, A J, Obdeijn, I M, Kaas, R, Tilanus-Linthorst, M M, Boetes, C, Loo, C E, Wasser, M N, Bergers, E, Kok, T, Muller, S H, Peterse, H, Tollenaar, R A, Hoogerbrugge, N, Meijer, S, Bartels, C C, Seynaeve, C, Hooning, M J, Kriege, M, Schmitz, P I, Oosterwijk, J C, Koning, H J, Rutgers, E J & Klijn, JG 2010, ' BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study ', Journal of Clinical Oncology, vol. 28, no. 36, pp. 5265-5273 . https://doi.org/10.1200/JCO.2009.27.2294
Journal of Clinical Oncology, 28, 5265-73
Journal of Clinical Oncology, 28(36), 5265-5273. AMER SOC CLINICAL ONCOLOGY
Journal of clinical oncology, 28(36), 5265-5273. American Society of Clinical Oncology
Journal of Clinical Oncology, 28, 36, pp. 5265-73
Journal of Clinical Oncology, 28(36), 5265-5273. American Society of Clinical Oncology

Purpose The Dutch MRI Screening Study on early detection of hereditary breast cancer started in 1999. We evaluated the long-term results including separate analyses of BRCA1 and BRCA2 mutation carriers and first results on survival. Patients and Meth

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c382bc2e842671d2251cac6dec54f92d
https://hdl.handle.net/2066/88479

Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer

Autor: Nicoline Hoogerbrugge, A. Peter E. Besnard, Siebren Meijer, Radu A. Manoliu, H. M. Zonderland, Inge Marie Obdeijn, Mieke Kriege, Jan G. M. Klijn, Caroline Seynaeve, Jan C. Oosterwijk, Sara H. Muller, Reini Kaas, Madeleine M.A. Tilanus-Linthorst, Harry J. de Koning, Rob A. E. M. Tollenaar, Theo Kok, Emiel J. Th. Rutgers, Cecile T. M. Brekelmans, C.C.M. Bartels, Carla Boetes

Publikováno v: Breast Cancer Research and Treatment, 100, 1, pp. 109-19
Breast Cancer Research and Treatment, 100, 109-19
Breast Cancer Research and Treatment, 100(1), 109-119. SPRINGER
Breast cancer research and treatment, 100(1), 109-119. Springer New York
Breast Cancer Research and Treatment, 100(1), 109-119. Springer New York

Contains fulltext : 49322.pdf (Publisher’s version ) (Closed access) BACKGROUND: The MRISC study is a screening study, in which women with an increased risk of hereditary breast cancer are screened by a yearly mammography and MRI, and half-yearly c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b48e874c1ebcb352a5662d3c1824d07b
https://doi.org/10.1007/s10549-006-9230-z

Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition

Autor: Harry J. de Koning, Radu A. Manoliu, Cecile T. M. Brekelmans, Mieke Kriege, H. M. Zonderland, Theo Kok, Jan G. M. Klijn, Sara H. Muller, Carla Boetes, Inge Marie Obdeijn, Emiel J. Th. Rutgers

Publikováno v: Cancer. 106:2318-2326

BACKGROUND. Within the Dutch MRI Screening (MRISC) study, a Dutch multicenter screening study for hereditary breast cancer, the authors investigated whether previously reported increased diagnostic accuracy of magnetic resonance imaging (MRI) compare

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::929f76b8c3c0f4301897619e42247a71
https://doi.org/10.1002/cncr.21863

Results of a randomised phase II study of cisplatin plus 5-fluorouracil versus cisplatin plus 5-fluorouracil with a-interferon in metastatic pancreatic cancer: an EORTC gastrointestinal tract cancer group trial

Autor: Benoit Baron, D.J.T. Wagener, Theo Kok, André S. Th. Planting, M.L. Couvreur, Jacques Wils

Publikováno v: European Journal of Cancer, 38, 648-653. Elsevier Ltd.

A randomised phase II study of 5-fluorouracil (5-FU) plus cisplatin (CDDP) with or without alpha-interferon 2b was performed in patients with pancreatic cancer with measurable metastatic disease outside the pancreas. The treatment in arm A consisted

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65c71198800f11f61b3e04360287c17e
https://hdl.handle.net/1765/64591

Splenic artery aneurysms in liver transplant patients

Autor: Koert P. de Jong, Elizabeth B. Haagsma, Ids J. Klompmaker, Paul M. J. G. Peeters, László Kóbori, Maarten J. H. Slooff, Theo Kok, Marjan J. van der Kolk

Publikováno v: Journal of Hepatology. 27:890-893

Background/Aims: The purpose of the study was to investigate the incidence of and risk factors for splenic artery aneurysms in liver transplant patients. Methods: Medical records and the pre- and 1-year postoperative angiograms of 337 liver transplan

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9d7f95120965c8512c2392a5b0ebe5a7
https://doi.org/10.1016/s0168-8278(97)80327-3